MedTrace Logo

Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT

NCT01724749 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2012-11-12

No results posted yet for this study

Summary

The purpose of the CAMONA study is to demonstrate the feasibility of cardiovascular molecular calcification (CMC) assessment by means of 18F-sodium-fluoride (18F-NaF) positron emission tomography (PET) computed tomography (CT) in a prospective cohort of healthy control subjects and subjects with cardiovascular disease.

Conditions

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Poul F Høilund-Carlsen, MD, DMSc · Odense University Hospital

  • Björn A Blomberg, MD, MSc · Odense University Hospital

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-11-30
Completion
2016-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724749 on ClinicalTrials.gov